What is the appropriate pre‑operative antimicrobial prophylaxis for clean‑contaminated urologic procedures such as transurethral resection of the prostate, ureteroscopy, percutaneous nephrolithotomy, and bladder stone removal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Antibiotic Prophylaxis for Clean-Contaminated Urologic Procedures

For clean-contaminated urologic procedures including TURP, ureteroscopy, percutaneous nephrolithotomy, and bladder stone removal, administer a single dose of antimicrobial prophylaxis 30-60 minutes before the procedure, with cefazolin (2g IV) as the first-line agent for most procedures, or gentamicin (5 mg/kg IV) as an alternative, and discontinue prophylaxis within 24 hours. 1, 2, 1

Core Principles

The most recent high-quality guidelines establish that antimicrobial prophylaxis is mandatory for endoscopic urologic procedures with mucosal trauma to prevent serious postoperative complications including sepsis 1. The 2019 IDSA guideline provides strong evidence (moderate-quality) that these procedures in the presence of bacteriuria represent heavily contaminated surgical fields requiring prophylaxis.

Timing and Duration

  • Initiate prophylaxis 30-60 minutes before surgical incision (120 minutes for fluoroquinolones and vancomycin if used) 2
  • Single-dose prophylaxis is sufficient for most procedures 1, 3
  • Discontinue within 24 hours of procedure completion 2
  • Redose intraoperatively only if procedure duration exceeds two half-lives of the initial dose 2

Procedure-Specific Recommendations

Transurethral Resection of Prostate (TURP)

  • Prophylaxis is mandatory 3, 4, 5
  • First-line: Cefazolin 2g IV or second-generation cephalosporin 6, 7, 4
  • Recent network meta-analysis demonstrates significant reduction in early bacteriuria (RR 0.32), septicemia (RR 0.37), and fever (RR 0.60) with prophylaxis 5

Ureteroscopy with Stone Manipulation

  • Prophylaxis is indicated 3, 4
  • First-line: Trimethoprim-sulfamethoxazole single dose 4
  • Alternative: Cefazolin or gentamicin 6
  • Stone manipulation specifically increases infection risk and mandates prophylaxis 6

Percutaneous Nephrolithotomy

  • Prophylaxis is mandatory 3, 4
  • First-line: Trimethoprim-sulfamethoxazole or cefazolin 4
  • Alternative: Gentamicin 5 mg/kg IV 6

Bladder Stone Removal/TURBT

  • Prophylaxis recommended for high-risk patients 3, 4
  • First-line: Aminopenicillin plus β-lactamase inhibitor or cefazolin 4
  • Risk stratification based on patient immunocompetence and presence of bacteriuria

Pre-Procedure Screening

Obtain urine culture prior to the procedure and use targeted antimicrobial therapy rather than empiric coverage 1. This weak recommendation (very low-quality evidence) reflects practical challenges but aligns with antimicrobial stewardship principles.

For patients with documented asymptomatic bacteriuria:

  • Screen and treat prior to endoscopic procedures with mucosal trauma (strong recommendation) 1
  • Initiate targeted therapy 30-60 minutes before the procedure 1
  • Use 1-2 doses rather than prolonged courses 1

Antibiotic Selection Algorithm

First-Line Agents:

  1. Cefazolin 2g IV - Most clean-contaminated urologic procedures 6, 7, 4
  2. Gentamicin 5 mg/kg IV - Alternative for stone procedures 6, 4
  3. Trimethoprim-sulfamethoxazole - Ureteroscopy, PCNL 4

Second-Line (β-lactam allergy):

  • Gentamicin 1.5 mg/kg IV plus vancomycin 1g IV (infuse over 1-2 hours) 6
  • Vancomycin requires 120-minute pre-incision timing 2

Specific Considerations:

  • Fluoroquinolones have no routine role in urologic surgical prophylaxis except transrectal prostate biopsy 8
  • Avoid empiric fluoroquinolones due to resistance concerns and stewardship principles 8

Critical Pitfalls to Avoid

  1. Do NOT extend prophylaxis beyond 24 hours - This converts prophylaxis to therapy without evidence of benefit and increases resistance 2

  2. Do NOT use prophylaxis for simple diagnostic cystoscopy in patients without risk factors or sterile urine 3, 4

  3. Do NOT delay prophylaxis - Tissue levels must be adequate at time of incision; late administration negates benefit 2

  4. Do NOT omit prophylaxis for stone manipulation procedures - These are classified as higher-risk procedures requiring coverage 6, 3

Special Populations

Patients with Indwelling Catheters

  • Catheter colonization is expected; consider culture-directed therapy 24-48 hours before catheter removal if clinically indicated 2
  • No evidence supports routine prophylaxis at catheter removal in absence of bacteriuria screening 1

Immunocompromised Patients

  • Consider broader coverage or extended single-dose prophylaxis
  • Maintain same timing and duration principles 6

Quality Assurance

The 2024 German AWMF S3 guideline emphasizes that prophylaxis is a rigorously justified and time-limited intervention 9, 10. Discontinuation at wound closure should be the universal standard, with single-dose prophylaxis representing optimal stewardship-oriented practice 9, 10.

The convergence of the 2019 IDSA 1, 2020 AUA 3, 2024 EAU 4, and 2024 AWMF 9, 10 guidelines demonstrates strong international consensus on these core principles, differing primarily in procedural granularity rather than fundamental approach.

References

Research

Antibiotic Prophylaxis in Men Undergoing Transurethral Resection of Prostate: A Systematic Review and Network Meta-Analysis.

International journal of urology : official journal of the Japanese Urological Association, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.